Long-term follow-up and safety of patients after an upfront therapy with Letrozole for early breast cancer in routine clinical care: the PreFace study : GebFra Science = Langfristige Nachbeobachtung und Sicherheit im klinischen Alltag bei Patientinnen nach Upfront-Therapie mit Letrozol zur Behandlung von Brustkrebs im Frühstadium : die PreFace-Studie

Adjuvant treatment of patients with early-stage breast cancer (BC) should include an aromatase inhibitor (AI). Especially patients with a high recurrence risk might benefit from an upfront therapy with an AI for a minimum of five years. Nevertheless, not much is known about the patient selection for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hack, Carolin Christine (VerfasserIn) , Maass, Nicolai (VerfasserIn) , Aktas, Bahriye (VerfasserIn) , Kümmel, Sherko (VerfasserIn) , Thomssen, Christoph (VerfasserIn) , Wolf, Christopher (VerfasserIn) , Kolberg, Hans-Christian (VerfasserIn) , Brucker, Cosima (VerfasserIn) , Janni, Wolfgang (VerfasserIn) , Dall, Peter (VerfasserIn) , Schneeweiss, Andreas (VerfasserIn) , Marmé, Frederik (VerfasserIn) , Ruebner, Matthias (VerfasserIn) , Theuser, Anna-Katharin (VerfasserIn) , Hofmann, Nadine M. (VerfasserIn) , Böhm, Sybille (VerfasserIn) , Almstedt, Katrin (VerfasserIn) , Kellner, Sara (VerfasserIn) , Nabieva, Naiba (VerfasserIn) , Gass, Paul (VerfasserIn) , Sütterlin, Marc (VerfasserIn) , Lück, Hans-Joachim (VerfasserIn) , Schmatloch, Sabine (VerfasserIn) , Kalder, Matthias (VerfasserIn) , Uleer, Christoph (VerfasserIn) , Juhasz-Böss, Ingolf (VerfasserIn) , Hanf, Volker (VerfasserIn) , Jackisch, Christian (VerfasserIn) , Müller, Volkmar (VerfasserIn) , Rack, Brigitte (VerfasserIn) , Belleville, Erik (VerfasserIn) , Wallwiener, Diethelm (VerfasserIn) , Rody, Achim (VerfasserIn) , Rauh, Claudia (VerfasserIn) , Bayer, Christian M. (VerfasserIn) , Uhrig, Sabrina (VerfasserIn) , Goossens, Chloë (VerfasserIn) , Huebner, Hanna (VerfasserIn) , Brucker, Sara Y. (VerfasserIn) , Häberle, Lothar (VerfasserIn) , Fehm, Tanja N. (VerfasserIn) , Hein, Alexander (VerfasserIn) , Fasching, Peter A. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 08. Februar 2024
In: Geburtshilfe und Frauenheilkunde
Year: 2024, Jahrgang: 84, Heft: 2, Pages: 185-195
ISSN:1438-8804
DOI:10.25673/115583
Online-Zugang:Resolving-System, kostenfrei: https://doi.org/10.25673/115583
Verlag, kostenfrei, Volltext: https://doi.org/10.1055/a-2238-3153
Volltext
Verfasserangaben:authors: Carolin C. Hack, Nicolai Maass, Bahriye Aktas, Sherko Kümmel, Christoph Thomssen, Christopher Wolf, Hans-Christian Kolberg, Cosima Brucker, Wolfgang Janni, Peter Dall, Andreas Schneeweiss, Frederik Marme, Matthias Ruebner, Anna-Katharin Theuser, Nadine M. Hofmann, Sybille Böhm, Katrin Almstedt, Sara Kellner, Naiba Nabieva, Paul Gass, Marc W. Sütterlin, Hans-Joachim Lück, Sabine Schmatloch, Matthias Kalder, Christoph Uleer, Ingolf Juhasz-Böss, Volker Hanf, Christian Jackisch, Volkmar Müller, Brigitte Rack, Erik Belleville, Diethelm Wallwiener, Achim Rody, Claudia Rauh, Christian M. Bayer, Sabrina Uhrig, Chloë Goossens, Hanna Huebner, Sara Y. Brucker, Lothar Häberle, Tanja N. Fehm, Alexander Hein, Peter A. Fasching

MARC

LEADER 00000caa a2200000 c 4500
001 1885087861
003 DE-627
005 20250716211737.0
007 cr uuu---uuuuu
008 240405s2024 xx |||||o 00| ||eng c
024 7 |a 10.1055/a-2238-3153  |2 doi 
024 7 |a 10.25673/115583  |2 doi 
035 |a (DE-627)1885087861 
035 |a (DE-599)KXP1885087861 
035 |a (OCoLC)1528013975 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hack, Carolin Christine  |d 1984-  |e VerfasserIn  |0 (DE-588)1029580871  |0 (DE-627)733819001  |0 (DE-576)377442631  |4 aut 
245 1 0 |a Long-term follow-up and safety of patients after an upfront therapy with Letrozole for early breast cancer in routine clinical care  |b the PreFace study : GebFra Science = Langfristige Nachbeobachtung und Sicherheit im klinischen Alltag bei Patientinnen nach Upfront-Therapie mit Letrozol zur Behandlung von Brustkrebs im Frühstadium : die PreFace-Studie  |c authors: Carolin C. Hack, Nicolai Maass, Bahriye Aktas, Sherko Kümmel, Christoph Thomssen, Christopher Wolf, Hans-Christian Kolberg, Cosima Brucker, Wolfgang Janni, Peter Dall, Andreas Schneeweiss, Frederik Marme, Matthias Ruebner, Anna-Katharin Theuser, Nadine M. Hofmann, Sybille Böhm, Katrin Almstedt, Sara Kellner, Naiba Nabieva, Paul Gass, Marc W. Sütterlin, Hans-Joachim Lück, Sabine Schmatloch, Matthias Kalder, Christoph Uleer, Ingolf Juhasz-Böss, Volker Hanf, Christian Jackisch, Volkmar Müller, Brigitte Rack, Erik Belleville, Diethelm Wallwiener, Achim Rody, Claudia Rauh, Christian M. Bayer, Sabrina Uhrig, Chloë Goossens, Hanna Huebner, Sara Y. Brucker, Lothar Häberle, Tanja N. Fehm, Alexander Hein, Peter A. Fasching 
246 3 1 |a Langfristige Nachbeobachtung und Sicherheit im klinischen Alltag bei Patientinnen nach Upfront-Therapie mit Letrozol zur Behandlung von Brustkrebs im Frühstadium  |b die PreFace-Studie 
264 1 |c 08. Februar 2024 
300 |b Diagramme 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 17.03.2025 
520 |a Adjuvant treatment of patients with early-stage breast cancer (BC) should include an aromatase inhibitor (AI). Especially patients with a high recurrence risk might benefit from an upfront therapy with an AI for a minimum of five years. Nevertheless, not much is known about the patient selection for this population in clinical practice. Therefore, this study analyzed the prognosis and patient characteristics of postmenopausal patients selected for a five-year upfront letrozole therapy. From 2009 to 2011, 3529 patients were enrolled into the adjuvant phase IV PreFace clinical trial (NCT01908556). Postmenopausal hormone receptor-positive BC patients, for whom an upfront five-year therapy with letrozole (2.5 mg/day) was indicated, were eligible. Disease-free survival (DFS), overall survival (OS) and safety in relation to patient and tumor characteristics were assessed. 3297 patients started letrozole therapy. The majority of patients (n = 1639, 57%) completed the five-year treatment. 34.5% of patients continued with endocrine therapy after the mandated five-year endocrine treatment. Five-year DFS rates were 89% (95% CI: 88-90%) and five-year OS rates were 95% (95% CI: 94-96%). In subgroup analyses, DFS rates were 83%, 84% and 78% for patients with node-positive disease, G3 tumor grading, and pT3 tumors respectively. The main adverse events (any grade) were pain and hot flushes (66.8% and 18.3% of patients). The risk profile of postmenopausal BC patients selected for a five-year upfront letrozole therapy showed a moderate recurrence and death risk. However, in subgroups with unfavorable risk factors, prognosis warrants an improvement, which might be achieved with novel targeted therapies. 
540 |q DE-3  |a Namensnennung - Nicht kommerziell - Keine Bearbeitungen 4.0 International  |f CC BY-NC-ND 4.0  |2 cc  |u https://creativecommons.org/licenses/by-nc-nd/4.0/ 
700 1 |a Maass, Nicolai  |e VerfasserIn  |4 aut 
700 1 |a Aktas, Bahriye  |e VerfasserIn  |4 aut 
700 1 |a Kümmel, Sherko  |e VerfasserIn  |4 aut 
700 1 |a Thomssen, Christoph  |e VerfasserIn  |0 (DE-588)1207932027  |0 (DE-627)1694239217  |4 aut 
700 1 |a Wolf, Christopher  |e VerfasserIn  |4 aut 
700 1 |a Kolberg, Hans-Christian  |e VerfasserIn  |4 aut 
700 1 |a Brucker, Cosima  |e VerfasserIn  |4 aut 
700 1 |a Janni, Wolfgang  |e VerfasserIn  |4 aut 
700 1 |a Dall, Peter  |e VerfasserIn  |4 aut 
700 1 |a Schneeweiss, Andreas  |d 1961-  |e VerfasserIn  |0 (DE-588)109972554  |0 (DE-627)632849630  |0 (DE-576)327251859  |4 aut 
700 1 |a Marmé, Frederik  |d 1974-  |e VerfasserIn  |0 (DE-588)132561972  |0 (DE-627)52394893X  |0 (DE-576)299226549  |4 aut 
700 1 |a Ruebner, Matthias  |e VerfasserIn  |4 aut 
700 1 |a Theuser, Anna-Katharin  |e VerfasserIn  |4 aut 
700 1 |a Hofmann, Nadine M.  |e VerfasserIn  |4 aut 
700 1 |a Böhm, Sybille  |e VerfasserIn  |4 aut 
700 1 |a Almstedt, Katrin  |e VerfasserIn  |4 aut 
700 1 |a Kellner, Sara  |e VerfasserIn  |4 aut 
700 1 |a Nabieva, Naiba  |e VerfasserIn  |4 aut 
700 1 |a Gass, Paul  |e VerfasserIn  |4 aut 
700 1 |a Sütterlin, Marc  |d 1967-  |e VerfasserIn  |0 (DE-588)102644067X  |0 (DE-627)72673389X  |0 (DE-576)371782651  |4 aut 
700 1 |a Lück, Hans-Joachim  |e VerfasserIn  |4 aut 
700 1 |a Schmatloch, Sabine  |e VerfasserIn  |4 aut 
700 1 |a Kalder, Matthias  |e VerfasserIn  |4 aut 
700 1 |a Uleer, Christoph  |e VerfasserIn  |4 aut 
700 1 |a Juhasz-Böss, Ingolf  |e VerfasserIn  |4 aut 
700 1 |a Hanf, Volker  |e VerfasserIn  |4 aut 
700 1 |a Jackisch, Christian  |e VerfasserIn  |4 aut 
700 1 |a Müller, Volkmar  |e VerfasserIn  |4 aut 
700 1 |a Rack, Brigitte  |e VerfasserIn  |4 aut 
700 1 |a Belleville, Erik  |e VerfasserIn  |4 aut 
700 1 |a Wallwiener, Diethelm  |e VerfasserIn  |4 aut 
700 1 |a Rody, Achim  |e VerfasserIn  |4 aut 
700 1 |a Rauh, Claudia  |e VerfasserIn  |4 aut 
700 1 |a Bayer, Christian M.  |e VerfasserIn  |4 aut 
700 1 |a Uhrig, Sabrina  |e VerfasserIn  |4 aut 
700 1 |a Goossens, Chloë  |e VerfasserIn  |4 aut 
700 1 |a Huebner, Hanna  |e VerfasserIn  |4 aut 
700 1 |a Brucker, Sara Y.  |e VerfasserIn  |4 aut 
700 1 |a Häberle, Lothar  |e VerfasserIn  |4 aut 
700 1 |a Fehm, Tanja N.  |e VerfasserIn  |4 aut 
700 1 |a Hein, Alexander  |e VerfasserIn  |4 aut 
700 1 |a Fasching, Peter A.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Geburtshilfe und Frauenheilkunde  |d Stuttgart : Thieme, 1980  |g 84(2024), 2, Seite 185-195  |h Online-Ressource  |w (DE-627)324451970  |w (DE-600)2026496-3  |w (DE-576)279447663  |x 1438-8804  |7 nnas  |a Long-term follow-up and safety of patients after an upfront therapy with Letrozole for early breast cancer in routine clinical care the PreFace study : GebFra Science = Langfristige Nachbeobachtung und Sicherheit im klinischen Alltag bei Patientinnen nach Upfront-Therapie mit Letrozol zur Behandlung von Brustkrebs im Frühstadium : die PreFace-Studie 
773 1 8 |g volume:84  |g year:2024  |g number:2  |g pages:185-195  |g extent:11  |a Long-term follow-up and safety of patients after an upfront therapy with Letrozole for early breast cancer in routine clinical care the PreFace study : GebFra Science = Langfristige Nachbeobachtung und Sicherheit im klinischen Alltag bei Patientinnen nach Upfront-Therapie mit Letrozol zur Behandlung von Brustkrebs im Frühstadium : die PreFace-Studie 
856 4 0 |u https://doi.org/10.25673/115583  |x Resolving-System  |z kostenfrei 
856 4 0 |u https://doi.org/10.1055/a-2238-3153  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250317 
993 |a Article 
994 |a 2024 
998 |g 102644067X  |a Sütterlin, Marc  |m 102644067X:Sütterlin, Marc  |d 60000  |d 61300  |e 60000PS102644067X  |e 61300PS102644067X  |k 0/60000/  |k 1/60000/61300/  |p 21 
998 |g 132561972  |a Marmé, Frederik  |m 132561972:Marmé, Frederik  |d 60000  |d 61300  |d 50000  |e 60000PM132561972  |e 61300PM132561972  |e 50000PM132561972  |k 0/60000/  |k 1/60000/61300/  |k 0/50000/  |p 12 
998 |g 109972554  |a Schneeweiss, Andreas  |m 109972554:Schneeweiss, Andreas  |d 910000  |d 910400  |d 50000  |e 910000PS109972554  |e 910400PS109972554  |e 50000PS109972554  |k 0/910000/  |k 1/910000/910400/  |k 0/50000/  |p 11 
999 |a KXP-PPN1885087861  |e 4687682057 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"person":[{"given":"Carolin Christine","role":"aut","display":"Hack, Carolin Christine","family":"Hack"},{"given":"Nicolai","role":"aut","family":"Maass","display":"Maass, Nicolai"},{"family":"Aktas","display":"Aktas, Bahriye","given":"Bahriye","role":"aut"},{"role":"aut","given":"Sherko","family":"Kümmel","display":"Kümmel, Sherko"},{"family":"Thomssen","display":"Thomssen, Christoph","given":"Christoph","role":"aut"},{"family":"Wolf","display":"Wolf, Christopher","given":"Christopher","role":"aut"},{"given":"Hans-Christian","role":"aut","display":"Kolberg, Hans-Christian","family":"Kolberg"},{"role":"aut","given":"Cosima","display":"Brucker, Cosima","family":"Brucker"},{"display":"Janni, Wolfgang","family":"Janni","given":"Wolfgang","role":"aut"},{"given":"Peter","role":"aut","family":"Dall","display":"Dall, Peter"},{"family":"Schneeweiss","display":"Schneeweiss, Andreas","role":"aut","given":"Andreas"},{"role":"aut","given":"Frederik","family":"Marmé","display":"Marmé, Frederik"},{"family":"Ruebner","display":"Ruebner, Matthias","given":"Matthias","role":"aut"},{"role":"aut","given":"Anna-Katharin","family":"Theuser","display":"Theuser, Anna-Katharin"},{"given":"Nadine M.","role":"aut","family":"Hofmann","display":"Hofmann, Nadine M."},{"display":"Böhm, Sybille","family":"Böhm","role":"aut","given":"Sybille"},{"role":"aut","given":"Katrin","display":"Almstedt, Katrin","family":"Almstedt"},{"display":"Kellner, Sara","family":"Kellner","role":"aut","given":"Sara"},{"display":"Nabieva, Naiba","family":"Nabieva","role":"aut","given":"Naiba"},{"role":"aut","given":"Paul","display":"Gass, Paul","family":"Gass"},{"role":"aut","given":"Marc","display":"Sütterlin, Marc","family":"Sütterlin"},{"given":"Hans-Joachim","role":"aut","display":"Lück, Hans-Joachim","family":"Lück"},{"given":"Sabine","role":"aut","family":"Schmatloch","display":"Schmatloch, Sabine"},{"given":"Matthias","role":"aut","display":"Kalder, Matthias","family":"Kalder"},{"given":"Christoph","role":"aut","family":"Uleer","display":"Uleer, Christoph"},{"family":"Juhasz-Böss","display":"Juhasz-Böss, Ingolf","given":"Ingolf","role":"aut"},{"display":"Hanf, Volker","family":"Hanf","given":"Volker","role":"aut"},{"given":"Christian","role":"aut","display":"Jackisch, Christian","family":"Jackisch"},{"role":"aut","given":"Volkmar","display":"Müller, Volkmar","family":"Müller"},{"role":"aut","given":"Brigitte","display":"Rack, Brigitte","family":"Rack"},{"display":"Belleville, Erik","family":"Belleville","given":"Erik","role":"aut"},{"display":"Wallwiener, Diethelm","family":"Wallwiener","given":"Diethelm","role":"aut"},{"display":"Rody, Achim","family":"Rody","given":"Achim","role":"aut"},{"display":"Rauh, Claudia","family":"Rauh","role":"aut","given":"Claudia"},{"role":"aut","given":"Christian M.","family":"Bayer","display":"Bayer, Christian M."},{"role":"aut","given":"Sabrina","display":"Uhrig, Sabrina","family":"Uhrig"},{"role":"aut","given":"Chloë","display":"Goossens, Chloë","family":"Goossens"},{"role":"aut","given":"Hanna","family":"Huebner","display":"Huebner, Hanna"},{"role":"aut","given":"Sara Y.","family":"Brucker","display":"Brucker, Sara Y."},{"role":"aut","given":"Lothar","display":"Häberle, Lothar","family":"Häberle"},{"display":"Fehm, Tanja N.","family":"Fehm","role":"aut","given":"Tanja N."},{"role":"aut","given":"Alexander","family":"Hein","display":"Hein, Alexander"},{"display":"Fasching, Peter A.","family":"Fasching","role":"aut","given":"Peter A."}],"physDesc":[{"extent":"11 S.","noteIll":"Diagramme"}],"name":{"displayForm":["authors: Carolin C. Hack, Nicolai Maass, Bahriye Aktas, Sherko Kümmel, Christoph Thomssen, Christopher Wolf, Hans-Christian Kolberg, Cosima Brucker, Wolfgang Janni, Peter Dall, Andreas Schneeweiss, Frederik Marme, Matthias Ruebner, Anna-Katharin Theuser, Nadine M. Hofmann, Sybille Böhm, Katrin Almstedt, Sara Kellner, Naiba Nabieva, Paul Gass, Marc W. Sütterlin, Hans-Joachim Lück, Sabine Schmatloch, Matthias Kalder, Christoph Uleer, Ingolf Juhasz-Böss, Volker Hanf, Christian Jackisch, Volkmar Müller, Brigitte Rack, Erik Belleville, Diethelm Wallwiener, Achim Rody, Claudia Rauh, Christian M. Bayer, Sabrina Uhrig, Chloë Goossens, Hanna Huebner, Sara Y. Brucker, Lothar Häberle, Tanja N. Fehm, Alexander Hein, Peter A. Fasching"]},"relHost":[{"id":{"issn":["1438-8804"],"zdb":["2026496-3"],"doi":["10.1055/s-00000020"],"eki":["324451970"]},"recId":"324451970","physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Long-term follow-up and safety of patients after an upfront therapy with Letrozole for early breast cancer in routine clinical care the PreFace study : GebFra Science = Langfristige Nachbeobachtung und Sicherheit im klinischen Alltag bei Patientinnen nach Upfront-Therapie mit Letrozol zur Behandlung von Brustkrebs im Frühstadium : die PreFace-StudieGeburtshilfe und Frauenheilkunde","note":["Erscheint monatlich","Gesehen am 08.11.2024"],"origin":[{"publisher":"Thieme","dateIssuedKey":"1980","dateIssuedDisp":"1980-","publisherPlace":"Stuttgart ; New York, NY"}],"pubHistory":["Nachgewiesen 40.1980 -"],"title":[{"title_sort":"Geburtshilfe und Frauenheilkunde","title":"Geburtshilfe und Frauenheilkunde"}],"part":{"extent":"11","volume":"84","year":"2024","pages":"185-195","issue":"2","text":"84(2024), 2, Seite 185-195"},"titleAlt":[{"title":"GEBFRA"}],"language":["ger"]}],"recId":"1885087861","id":{"doi":["10.1055/a-2238-3153","10.25673/115583"],"eki":["1885087861"]},"title":[{"title":"Long-term follow-up and safety of patients after an upfront therapy with Letrozole for early breast cancer in routine clinical care","subtitle":"the PreFace study : GebFra Science = Langfristige Nachbeobachtung und Sicherheit im klinischen Alltag bei Patientinnen nach Upfront-Therapie mit Letrozol zur Behandlung von Brustkrebs im Frühstadium : die PreFace-Studie","title_sort":"Long-term follow-up and safety of patients after an upfront therapy with Letrozole for early breast cancer in routine clinical care"}],"origin":[{"dateIssuedDisp":"08. Februar 2024","dateIssuedKey":"2024"}],"note":["Gesehen am 17.03.2025"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"titleTranslated":[{"translated":"Langfristige Nachbeobachtung und Sicherheit im klinischen Alltag bei Patientinnen nach Upfront-Therapie mit Letrozol zur Behandlung von Brustkrebs im Frühstadium"}]} 
SRT |a HACKCAROLILONGTERMFO0820